Search results
Childress Capital Advisors LLC Has $583,000 Position in Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 4 days agoChildress Capital Advisors LLC boosted its stake in Pfizer Inc. (NYSE:PFE – Free Report) by 2.2% during the 4th quarter, according to its most recent 13F filing with the Securities ...
Pfizer Inc. (NYSE:PFE) Position Increased by V Square Quantitative Management LLC
ETF DAILY NEWS· 2 days agoV Square Quantitative Management LLC increased its position in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 260.1% in the 4th quarter, according to the company in its ...
Pfizer Failure in Duchenne Muscular Dystrophy Trial Leaves Field Open for a Rival
Barrons.com· 4 days agoPfizer disclosed on May 7 that a child participating in another...
Pfizer (PFE) Phase III DMD Gene Therapy Study Misses Goal
Zacks via Yahoo Finance· 5 days agoPfizer's (PFE) phase III study, CIFFREO, fails to show improvement in motor function in ambulatory...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 5 days agoDespite a bevy of promising updates for its cancer treatments, Pfizer stock remains trapped below a...
Gateway - Quartz
Quartz· 6 hours agoThe company announced on Oct. 20 that it intends to sell the covid vaccine, marketed under the brand name Comirnaty, for $110 to $130 per dose. According to The People’s Vaccine Alliance, a ...
Pfizer gene therapy for Duchenne fails to meet goals of key trial
BioPharma Dive via Yahoo Finance· 5 days agoThe negative results from the Phase 3 study, called Ciffreo, come a little more than a month after ...
Pfizer (NYSE:PFE) Stock Price Down 0.9%
ETF DAILY NEWS· 3 days agoPfizer Inc. (NYSE:PFE – Get Free Report) was down 0.9% during trading on Thursday . The company traded as low as $27.20 and last traded at $27.41. Approximately 11,513,196 ...
COVID summer guide: How to navigate symptoms, variants and vaccines this season
Yahoo Life· 4 days agoWho should wait, and who should get vaccinated now? The CDC advises that everyone ages 5 and older...
Is It Too Late to Buy Pfizer Stock? | The Motley Fool
The Motley Fool· 4 days agoAre Pfizer's (PFE -0.43%) best days behind it? If the stock's critics are to be believed, the answer...
